BTG-002814 / Boston Scientific, UCL Cancer Institute  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BTG-002814 / Boston Scientific
VEROnA, NCT03291379: Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies

Completed
1
8
Europe
BTG-002814, vandetanib-eluting radiopaque beads
Boston Scientific Corporation, Biocompatibles UK Ltd
Carcinoma, Hepatocellular, Metastatic Colorectal Cancer
08/19
08/19

Download Options